Project Grant R15GM163260
- Federal Project Grant Award Summary Rowan University received a $170,900 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective August 1, 2025, through July 31, 2029. The award supports fundamental biomedical research investigating autophagy regulation in aging-induced muscle deterioration (sarcopenia) in mice. The research deliverables include: (1) defining the role of Golgi-associated...
- Federal Project Grant Award Summary Rutgers, The State University of New Jersey, Camden Division received a $151,870 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through August 31, 2029. The primary deliverable is the development and release of computational software tools designed to identify non-canonical junctions (NJs) in the SARS-CoV-2 transcriptome that...
- Federal Grant Award Summary Rutgers The State University of New Jersey received a $249,000 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through July 31, 2028. The award supports fundamental research investigating protein condensates and nuclear organization mechanisms in genomic integrity. Specifically, the research characterizes how tumor suppressors BRCA1...
- Federal Project Grant Summary Rutgers, The State University of New Jersey, Camden Division received a $423,734 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded February 12, 2026, with a completion date of December 31, 2030. The award funds the development of in vivo genetic and molecular platforms to investigate the co-evolution of cell-signaling proteins, specifically examining how...
- Federal Grant Award Summary Wright State University received a Project Grant award of $554,528 from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective March 1, 2026, through February 28, 2029. The award supports fundamental biomedical research investigating phosphatidylinositol 4-phosphate (PI4P) regulation at the Golgi complex and its novel roles in controlling plasma membrane lipid composition and...
- Federal Grant Award Summary Rutgers The State University of New Jersey received a $392,500 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective April 1, 2026 through March 31, 2031. The award supports fundamental research aimed at identifying novel approaches for modulating the activity of select potassium (K+) ion channels, which control electrical signaling throughout the body and...
- Federal Project Grant Award Summary Rutgers, The State University received a $487,500 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective May 11, 2026 through January 31, 2031. The award funds fundamental research investigating the mechanisms of adaptive immunity in RNA-targeting CRISPR-Cas13 systems. The research employs microbiological, genetic, high-throughput sequencing,...
- Federal Project Grant Award Summary Rutgers The State University of New Jersey received a $431,750 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective August 12, 2025, with completion targeted for May 31, 2030. The award funds fundamental research investigating how ecological interactions affect mutant fitness and evolution in microbial communities. The research addresses critical...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded a Project Grant of $528,560 to Missouri University of Science & Technology (NIGMS Biomedical Research and Research Training program, CFDA 93.859) effective June 1, 2026, through May 31, 2029. The project delivers fundamental biochemical and structural research on flavin-dependent N-monooxygenases, enzymes critical to siderophore biosynthesis in pathogenic organisms including Aspergillus fumigatus...
- Federal Grant Award Summary Rutgers University-Newark received a $581,440 Project Grant from the National Institute of General Medical Sciences under the Biomedical Research and Research Training program (CFDA 93.859), effective June 1, 2026, through May 31, 2031. The award funds the Initiative for Maximizing Student Development (IMSD) program, which provides comprehensive training and professional development services to approximately 10 graduate students, primarily in their first years of...
Rowan University received a $581,250 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded May 1, 2026, with a completion date of April 30, 2029. The grant funds fundamental research to elucidate the structural and biochemical mechanisms of the MRAS-SHOC2-PP1C (SMP) complex, which regulates the RAS-MAPK signaling pathway. The research deliverables include: (1) characterization of the molecular interactions and structural basis of SMP complex assembly and function; (2) development of novel chemical probes designed to selectively disrupt SMP complex activity; and (3) investigation of MRAS and SHOC2 roles in complex formation and regulation. The research employs an integrative methodological approach combining structural biology, chemical biology, medicinal chemistry, computational simulations, biophysical analyses, and cellular assays to define key molecular drivers of SMP complex activity. The ultimate research products—including structural data, chemical tool compounds, and functional mechanistic insights—are intended to serve as foundational resources for therapeutic development targeting aberrant RAS signaling in RAS-/RAF-driven malignancies and RASopathies. Research activities are conducted at the University's Glassboro, New Jersey facility.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $581.3k | 4/28/26 |